Ciprofloxacin 0.3% + dexamethasone 0.1% for the treatment for otitis media

Bibliography

• Roland PS. Chronic suppurative otitis media: a clinical overview. Ear Nose Throat J 2002;81(8 Suppl 1):8-10
   PubMedGoogle Scholar
• Verhoeff M, van der Veen EL, Rovers MM, et al. Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol 2006;70(1):1-12
   PubMed Web of Science ®Google Scholar
• Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am 2006;39(6):1237-55
   PubMed Web of Science ®Google Scholar
• Saunders JE, Raju RP, Boone JL, et al. Antibiotic resistance and otomycosis in the draining ear: culture results by diagnosis. Am J Otolaryngol 2011;32(6):470-6
   PubMed Web of Science ®Google Scholar
• Bath AP, Walsh RM, Bance ML, Rutka JA. Ototoxicity of topical gentamicin preparations. Laryngoscope 1999;109(7 Pt 1):1088-93
   PubMed Web of Science ®Google Scholar
• Oghan F, Apuhan T, Yilmaz F. Ototoxicity caused by topical administration of gentamicin versus tobramycin in rabbits. Int J Pediatr Otorhinolaryngol 2011;75(7):915-18
   PubMed Web of Science ®Google Scholar
• Pappas S, Nikolopoulos TP, Korres S, et al. Topical antibiotic ear drops: are they safe? Int J Clin Pract 2006;60(9):1115-9
   PubMed Web of Science ®Google Scholar
• Matz G, Rybak L, Roland PS, et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg 2004;130(3 Suppl):S79-82
   PubMed Web of Science ®Google Scholar
• Kaplan DM, Hehar SS, Bance ML, Rutka JA. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity. Laryngoscope 2002;112(4):689-95
   PubMed Web of Science ®Google Scholar
• van de Heyning PH, Pattyn SR, Valcke HD, et al. The use of fluoroquinolones in chronic otitis suppurativa. Pharm Weekbl Sci 1987;9(Suppl):S87-9
   PubMedGoogle Scholar
• Lenarz T. Chemotherapy of otitis media with ofloxacin. Drugs 1987;34(Suppl 1):139-43
   PubMedGoogle Scholar
• Yuen PW, Lau SK, Chau PY, et al. Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study. Am J Otol 1994;15(5):670-3
   PubMedGoogle Scholar
• Isaacson G, Rosenfeld RM. Care of the child with tympanostomy tubes. Pediatr Clin North Am 1996;43:1183-93
   PubMed Web of Science ®Google Scholar
• Hochman J, Blakley B, Abdoh A, et al. Post-tympanostomy tube otorrhea: a meta-analysis. Otolaryngol Head Neck Surg 2006;135:8-11
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Brown L, Cannon CR, et al. American Academy of Otolaryngology-Head Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 2006;134(Suppl 4):S4-23
   PubMed Web of Science ®Google Scholar
• Hannley M, Denneny JC III, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg 2000;122:934-40
   PubMed Web of Science ®Google Scholar
• Spektor Z, Jasek MC, Jasheway D, et al. Pharmacokinetics of CIP/DEX otic in pediatric and adolescent patients. Int J Pediatr Otorhinolaryngol 2008;72(1):97-102
   PubMed Web of Science ®Google Scholar
• Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006;118(3):e561-9
   PubMed Web of Science ®Google Scholar
• Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. Arch Otolaryngol Head Neck Surg 1990;116(5):557-9
   PubMedGoogle Scholar
• Esposito S, Noviello S, D'Errico G, Montanaro C. Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg 1992;118(8):842-4
   PubMedGoogle Scholar
• Roland PS, Kreisler LS, Reese B, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004;113(1 Pt 1):e40-6
   PubMed Web of Science ®Google Scholar
• Ciprodex (ciprofloxacin 0.3% and dexamethasome 0.1%) Sterile Otic Suspecsion. Product label from Alcon. Available from: http://ecatalog.alcon.com/PI/CiprodexOticSusp_us_en.pdf [Last accessed 26 August 2013]
   Google Scholar
• Roland PS, Dohar JE, Lanier BJ, et al. CIP/DEX AOMT Study Group. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg 2004;130(6):736-41
   PubMed Web of Science ®Google Scholar
• Roland PS, Pontius A, Wall MG, Waycaster CR. A cost threshold analysis of ciprofloxacin-dexamethasone versus ofloxacin for acute otitis media in pediatric patients with tympanostomy tubes. Clin Ther 2004;26(7):1168-78
   PubMed Web of Science ®Google Scholar
• Roland PS, Waycaster CR, Wall GM, Glass JD. An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients. Value Health 2006;9(4):219-26
   PubMed Web of Science ®Google Scholar
• Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003;113(12):2116-2
   PubMed Web of Science ®Google Scholar
• Thomas RG, Ojano-Dirain C, Antonelli PJ. Topical antibiotic treatment reduces tympanostomy tube biofilm formation. Laryngoscope 2011;121(5):1067-71
   PubMed Web of Science ®Google Scholar
• Jang CH, Park SY. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media. Clin Otolaryngol Allied Sci 2004;29(4):321-3
   PubMed Web of Science ®Google Scholar
• Weber PC, Roland PS, Hannley M, et al. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg 2004;130(3 Suppl):S89-94
   PubMed Web of Science ®Google Scholar
• Daniel SJ, Kozak FK, Fabian MC, et al. Expert round table of pediatric and general otolaryngologists, pediatricians, and family physicians. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol 2005;34(Suppl fd2):S60-3
   PubMedGoogle Scholar
• Daniel SJ, Munguia R. Ototoxicity of topical ciprofloxacin/dexamethasone otic suspension in a chinchilla animal model. Otolaryngol Head Neck Surg 2008;139(6):840-5
   PubMed Web of Science ®Google Scholar
• Lemke LE, McGee DH, Prieskorn DM, et al. Safety of ciprofloxacin and dexamethasone in the guinea pig middle ear. Arch Otolaryngol Head Neck Surg 2009;135(6):575-80
   PubMedGoogle Scholar
• Kavanagh KR, Parham K, Schoem SR. Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model. Arch Otolaryngol Head Neck Surg 2009;135(3):238-41
   PubMedGoogle Scholar
• Shefelbine LJ, Young PJ. Antonelli. Mitigation of hearing loss from semi-circular canal transaction in pseudomonal otitis media with ciprofloxacin-dexamethasone irrigation. Otol Neurotol 2006;27(2):265-9
   PubMed Web of Science ®Google Scholar
• Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child 2011;96(9):874-80
   PubMed Web of Science ®Google Scholar
• Force RW, Hart MC, Plummer SA, et al. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 1995;121(8):880-4
   PubMedGoogle Scholar
• Conroy PJ. New quinolone/steroid combination for topical treatment of acute otitis: early- and late-phase study results. Ear Nose Throat J 2003;82(8 Suppl 2):2-4
   PubMedGoogle Scholar
• Miró N. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension. Otolaryngol Head Neck Surg 2000;123(5):617-23
   PubMed Web of Science ®Google Scholar
• Buyten J, Kaufman G, Ryan M. Effects of ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane perforation healing. Otol Neurotol 2007;28(7):887-90
   Web of Science ®Google Scholar
• Hebda PA, Yuksel S, Dohar JE. Effects of ciprofloxacin-dexamethasone on myringotomy wound healing. Laryngoscope 2007;117(3):522-8
   PubMed Web of Science ®Google Scholar
• Antonelli PJ, Winterstein AG, Schultz GS. Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study. Otol Neurotol 2010;31(3):519-23
   PubMed Web of Science ®Google Scholar
• Roland PS, Wall M. Ciprofloxacin 0.3%/dexamethasone 0.1% topical drops for the management of otic infections. Expert Opin Pharmacother 2008;9(17):3129-35
   PubMed Web of Science ®Google Scholar